Australia markets closed

AFT Pharmaceuticals Limited (AFT.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
3.4500+0.0400 (+1.17%)
At close: 04:43PM NZDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
31/03/2019
Total revenue
140,023
129,834
113,105
105,597
85,127
Cost of revenue
76,802
68,539
64,364
57,332
44,397
Gross profit
63,221
61,295
48,741
48,265
40,730
Operating expenses
Research development
5,459
5,507
3,437
1,984
2,588
Selling general and administrative
40,037
36,104
35,222
35,314
33,742
Total operating expenses
46,540
42,655
39,763
38,079
36,649
Operating income or loss
16,681
18,640
8,978
10,186
4,081
Interest expense
2,590
2,435
3,441
8,052
8,417
Total other income/expenses net
1,357
1,432
1,242
10,239
1,716
Income before tax
16,375
18,685
7,887
12,877
-2,259
Income tax expense
-682
-1,163
105
185
168
Income from continuing operations
17,057
19,848
7,782
12,692
-2,427
Net income
17,057
19,848
7,782
12,692
-2,427
Net income available to common shareholders
17,057
19,848
7,782
12,692
-2,427
Basic EPS
-
0.19
0.08
0.13
-0.02
Diluted EPS
-
0.19
0.08
0.13
-0.02
Basic average shares
-
104,681
103,297
97,309
97,308
Diluted average shares
-
104,681
103,297
97,309
97,308
EBITDA
-
22,164
12,432
21,710
6,477